ExpreS2ion to present in Redeye Fight Cancer event and the Bio Innovation Leaders Summit
Hørsholm, Denmark, 22 January 2024 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") will participate in investor and R&D events in the coming weeks. This Wednesday, January 24[th], CEO Bent Frandsen will present at the Redeye thematic event, Fight Cancer. Furthermore, Senior VP of R&D and Technology Dr. Max Søgaard will present at the Bio Innovation Leaders Summit taking place on February 7[th] and 8[th].By attending relevant industry and investor events, the company aims to increase the awareness of its technology platform and its exciting